Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duloxetine Hydrochloride 60 mg or 120 mg Once Daily Compared With Placebo in Patients With Generalized Anxiety Disorder.

NCT00122824 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00122824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00122824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duloxetine Hydrochloride 60 mg or 120 mg Once Daily Compared With Placebo in Patients With Generalized Anxiety Disorder.
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2004
Completion date
September 30, 2005
Enrollment
480
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders